Received: 18 November 2020
Accepted: 26 February 2021
First Online: 1 April 2021
: There is no need for ethical approval in this consensus document.
: No individual person’s data in any form (including any individual details, images or videos) is presented in this consensus document. No case studies are reported.
: All authors, except LML, have received travel and accommodation supports from ETHICON (a member of the Johnson and Johnson Family of Companies) to attend and participate in the Asia Pacific Masters Surgical Site Infection Prevention symposium. KM has no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials disclosed in this manuscript. KYL is a consultant of Johnson and Johnson. MC has no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials disclosed in this manuscript. LML received an educational grant from 3 M for the development of the APSIC Guidelines for Prevention of SSI; however, 3 M was not involved in providing any input to the guidelines. PLR is the President of the Australasian College for Infection Prevention and Control. He is a member of the COVID Evidence Taskforce Steering Committee, the Infection Control Expert Group to the Department of Health, the Australian Strategic and Technical Advisory Group on AMR, the Healthcare Associated Infection Advisory Committee to the Australian Commission on Safety and Quality in Health Care, and a member of the Australian College of Nursing. He is also the recipient of a NHMRC Early Career Fellowship and has received research funding from the Rosemary Norman Foundation, Cardinal Health, Australian College of Nursing and the Cabrini Institute. ES has been invited as speaker and has on few occasions received honoraria from ETHICON and 3 M. MS is a member of the J&J Ethicon Speakers Bureau. WD is Director of Ethicon Global Health Economics and Market Access, a subsidiary of Johnson and Johnson, manufacturer of surgical sutures and wound closure devices. AS is Associate Director at Johnson and Johnson. CEE is a member of the J&J Ethicon Speakers Bureau.